Work

Supplemental Figure 4 from Alternative NHEJ Pathway Components Are Therapeutic Targets in High-Risk Neuroblastoma

Year: 2023

Type: supplementary-materials

Abstract: Supplemental Figure 4: Representative immunoblot demonstrating PARP1 cleavage in IMR32 cells in response to Lig3 siRNA knockdown.

DOI: 10.1158/1541-7786.22517007.v1

Authors: Erika A. Newman, Fujia Lu, Daniela Bashllari, Li Wang, Anthony W. Opipari, Valerie P. Castle

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362487358

Cites:

Cited by:

Related to: 10